Gurewich V, Pannell R
Thromb Res. 1986 Oct 15;44(2):217-28. doi: 10.1016/0049-3848(86)90137-4.
Clot lysis and non-specific plasminogen activation in human plasma by tissue tissue plasminogen activator (t-PA) and/or pro-urokinase (pro-UK) were studied. The fibrinolytic activity of pro-UK was expressed as latent units, i.e. measured after activation with plasmin on a fibrin plate against the reference standard. The t-PA unitage was assigned on a weight basis of a similar equivalence of 100,000 IU/mg. To simplify comparison, both activators were expressed in IU (1 IU = approximately 10 ng). At low concentration (1-50 IU/ml), t-PA induced more effective and more linear clot lysis, whereas pro-UK induced lysis was preceded by a lag phase. The two activators were equivalently effective at higher concentrations and saturated at the same lysis rate. Clots made from platelet rich plasma or whole blood were more responsive to lysis by pro-UK but not t-PA than corresponding platelet poor clots. At very low concentrations (2.5-5 IU/ml) of t-PA combined with moderate concentrations (25-50 IU/ml) of pro-UK, a synergistic effect on clot lysis, which was fibrin-specific, was observed. Plasminogen and fibrinogen and the appearance of plasmin-inhibitor complexes in plasma were measured after incubation with either activator with and without a clot present. Non-specific plasminogen activation occurred above a certain concentration of either activator but was found at lower concentrations of t-PA than pro-UK. In the absence of a clot, plasmin generation occurred with t-PA at about 30% of the concentration at which pro-UK induced a corresponding effect. It is concluded that there are important differences in the fibrinolytic and clot selective properties of t-PA and pro-UK, and that some of these properties may be complementary resulting in a fibrin specific, synergistic fibrinolytic effect.
研究了组织型纤溶酶原激活剂(t-PA)和/或尿激酶原(pro-UK)对人血浆中凝块溶解及非特异性纤溶酶原激活的作用。尿激酶原的纤溶活性以潜在单位表示,即在纤维蛋白平板上用纤溶酶激活后,相对于参考标准进行测量。t-PA的单位活性是根据100,000 IU/mg的相似等效重量确定的。为简化比较,两种激活剂均以IU表示(1 IU约等于10 ng)。在低浓度(1 - 50 IU/ml)时,t-PA诱导的凝块溶解更有效且更呈线性,而尿激酶原诱导的溶解之前有一个延迟期。两种激活剂在较高浓度时等效有效,且以相同的溶解速率达到饱和。由富含血小板血浆或全血制成的凝块比相应的贫血小板凝块对尿激酶原诱导的溶解更敏感,但对t-PA不敏感。在极低浓度(2.5 - 5 IU/ml)的t-PA与中等浓度(25 - 50 IU/ml)的尿激酶原联合使用时,观察到对凝块溶解有纤维蛋白特异性的协同作用。在有或无凝块存在的情况下,将血浆与任一种激活剂孵育后,测量血浆中的纤溶酶原、纤维蛋白原以及纤溶酶 - 抑制剂复合物的出现情况。在任一种激活剂的特定浓度以上会发生非特异性纤溶酶原激活,但发现t-PA的浓度低于尿激酶原。在无凝块的情况下,t-PA诱导纤溶酶生成的浓度约为尿激酶原诱导相应作用浓度的30%。结论是,t-PA和尿激酶原在纤溶和凝块选择性特性方面存在重要差异,并且其中一些特性可能具有互补性,从而产生纤维蛋白特异性的协同纤溶作用。